Artivion vs Inspire Medical Systems
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Artivion and Inspire Medical Systems side by side, using each one’s latest annual report. Here is what stands out:
- Inspire Medical Systems is the larger business, with $912M of revenue in fiscal 2025 against $441M for Artivion, about 2.1 times as much.
- Artivion kept more of each dollar of sales as operating profit (7.7% operating margin, against 5.6%).
- Inspire Medical Systems turned more of its sales into free cash flow (8.6% FCF margin, against 0.2%).
- Inspire Medical Systems earned a higher return on the capital invested in it (14.2%, against 3.9%).
Who comes out ahead
Of the 11 measures where higher (or lower) is clearly better, how many each company leads.
Artivion
AORT
2/11
Operating marginPiotroski F-score
Inspire Medical Systems
INSP
9/11
Revenue growth5-year growthGross marginNet marginFCF marginReturn on capitalReturn on equityNet debt / EBITDAShare count change
Side by side
Best in the row
| Latest fiscal year | AORT FY25 | INSP FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.1B | $2.1B |
| Revenue | $441M | $912M |
| Free cash flow | $0.8M | $78.5M |
| Net income | $9.8M | $145M |
| Growth | ||
| Revenue growth | 13.6% | 13.6% |
| 5-year growth | 11.8% | 51.2% |
| Share count change | 13.2% | −2.6% |
| Profitability | ||
| Gross margin | 64.4% | 85.4% |
| Operating margin | 7.7% | 5.6% |
| Net margin | 2.2% | 16.0% |
| FCF margin | 0.2% | 8.6% |
| Return on capital | 3.9% | 14.2% |
| Return on equity | 2.7% | 19.8% |
| Balance sheet | ||
| Net debt | $154M | −$308M |
| Net debt / EBITDA | 2.7x | −4.8x |
| Dividends and buybacks | $0.0M | $175M |
| Valuation & quality | ||
| P/E | — | 15.7x |
| Piotroski F-score | 7 | 5 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.